School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, People's Republic of China.
Shanghai Golden Toad Health CO. LTD., 2593 Dongfengle Road, Shanghai 202150, People's Republic of China.
Fitoterapia. 2018 Nov;131:215-220. doi: 10.1016/j.fitote.2018.10.023. Epub 2018 Oct 30.
Two new 19-norbufadienolides (1 and 2) and one new 14,15-epoxy bufadienolide (3) alongside 16 known bufadienolides (4-19) were isolated from Bufonis Venenum that originated from the skin and parotid venom glands of an Asiatic toad (Bufo bufo gargarizans Cantor). The structures of these bufadienolides were elucidated based on the interpretation of their HRESIMS and NMR data. Compound 1, which had a unique peroxide, was established through extensive single-crystal X-ray diffraction. The two 19-norbufadienolides exhibited more potent cardiotonic activity in the isolated toad heart model and lower cytotoxicity against U87, U251, and LN-18 cell lines than other bufadienolides, such as bufalin and bufotalin. The results suggested that 19-norbufadienolides might be more suitable for developing cardiotonic agents with low cytotoxicity.
从源自亚洲蟾蜍(Bufo bufo gargarizans Cantor)皮肤和腮腺毒液腺的蟾毒中分离得到了两个新的 19-去甲蟾蜍二烯醇内酯(1 和 2)和一个新的 14,15-环氧蟾蜍二烯醇内酯(3),以及 16 个已知的蟾蜍二烯醇内酯(4-19)。这些蟾蜍二烯醇内酯的结构是根据它们的 HRESIMS 和 NMR 数据的解释来阐明的。化合物 1 具有独特的过氧化物,通过广泛的单晶 X 射线衍射确定。两个 19-去甲蟾蜍二烯醇内酯在分离的蟾蜍心脏模型中表现出更强的强心活性,对 U87、U251 和 LN-18 细胞系的细胞毒性比其他蟾蜍二烯醇内酯(如蟾毒和蟾毒配基)低。结果表明,19-去甲蟾蜍二烯醇内酯可能更适合开发具有低细胞毒性的强心剂。